Abstract
Melatonin was isolated in the late 1950s and had been administered intravenously by 1960. Studies of its sedative/hypnotic effects soon followed (Dawson and Encel, 1993). Melatonin promotion to the public began in the mid-1990s.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anonymous. Melatonin. Briggs Update-Drugs in Pregnancy and lactation. 2002; 14: 28–9.
Anonymous. Melatonin. Med Lett Drugs Ther 1995; 37: 111–2.
Arendt J. In what circumstances is melatonin a useful sleep therapy? Consensus statement
WFSRS Focus Group, Dresden, November 1999. J Sleep Res 2000; 9: 397–8.
Bardazzi F, Placucci F, Neri I, et al. Fixed drug eruption due to melatonin. Acta Derm-Venereol 1998; 78: 69–70.
Bursztajn HJ. Melatonin therapy: from benzodiazepine-dependent insomnia to authenticity and autonomy [editorial]. Arch Intern Med 1999; 159: 2393–4.
Carman JS, Post RM, Buswell R, Goodwin FK. Negative effects of melatonin on depression. Am J Psychiatry 1976; 133: 1181–6.
Citera G, Arias MA, Maldonado-Cocco JA, et al., The effect of melatonin in patients with fibromyalgia: a pilot study. Clin Rheumatol 2000; 19: 9–13.
Dagan Y, Zisapel N, Nof D, et al. Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report. Eur Neuropsychopharmacol 1997; 7: 157–69.
Dalton EJ, Rotondi D, Levitan RD, et al. Use of slow-release melatonin in treatment-resistant depression. J Psychiatry Neurosci 2000; 25: 48–52.
Dawson D, Encel N. Melatonin and sleep in humans. J Pineal Res 1993; 15: 1–12.
DeMuro RL, Nafziger AN, Blask DE, et al. The absolute bioavailability of oral melatonin. J Clin Pharmacol 2000; 40: 781–4.
Ellis CM, Lemmens G, Parkes JD. Melatonin and insomnia. J Sleep Res 1996;5:61#-35.
Force RW, Hansen L, Bedell M. Psychotic episode after melatonin [letter]. Ann Pharmacother 1997; 31: 1408.
Garfinkel D, Laudon M, Nof D, Zisapel N. Improvement of sleep quality in elderly people by controlled-release melatonin. Lancet 1995; 346: 541–4.
Garfinkel D, Zisapel N, Wainstein J, Laudon M. Facilitation of benzodiazepine disontinuation by melatonin. Arch Intern Med 1999; 159: 2456–60.
Ghielmini M, Pagani O, de Jong J, et al. Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer. Br J Cancer 1999; 80: 1058–61.
Gordon N. The therapeutics of melatonin: a paediatric perspective. Brain Dev 2000; 22: 213–7.
Hahm H, Kujawa J, Augsburger L. Comparison of melatonin products against USP nutritional supplements standards and other criteria. J Am Pharm Assoc 1999; 39: 27–31.
Haimov I, Lavie P, Laudon M, et al. Melatonin replacement therapy of elderly insomniacs. Sleep 1995; 18: 598–603.
Hao H. Melatonin does not shift circadian phase in baboons. J Clin Endocrinol Metab 2000; 85: 3618–22.
Hartter S, Grozinger M, Weigmann H, et al. Increased bioavailability of oral melatonin after fluvoxamine coadministration. Clin Pharmacol Ther 2000; 67: 1–6.
Harumi T, Matsushima S. Separation and assay methods for melatonin and its precursors. J Chromatogr B Biomed Sci App12000; 747: 95–110.
Herxheimer A, Petrie KJ. Melatonin for preventing and treating jet lag (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software, 2001.
Holliman BJ, Chyka PA. Problems in assessment of acute melatonin overdose. South Med J 1997; 90: 451–3.
Iinuma F, Hamase K, Matsubayashi S, et al. Sensitive determination of melatonin by precolumn derivatization and reversed-phase high-performance liquid chromatography. J Chromatogr A 1999; 835: 67–72.
James M, Trema MO, Jones JS, Krohmer JR. Can melatonin improve adaptation to night shift? Am J Emerg Med 1998; 16: 367–70.
Lewy AJ, Bauer VK, Cutler NL, Sack RL. Melatonin treatment of winter depression: a pilot study. Psychiatry Res 1998; 77: 57–61.
Lissoni P, Barni S, Mandala M, et al. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumor patients with poor clinical status. Eur J Cancer 1999; 35: 1688–92.
Lissoni P, Barni S, Meregalli S, et al. Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone. BJM 1995; 71: 854–6.
Lissoni P, Barni S, Tancini G, et al., A randomized study with subcutaneous low-dose interleukin 2 alone v interleukin 2 plus the pineal hormone melatonin in advanced solid neoplasms other than renal cancer and melanoma. Br J Cancer 1994; 69: 196–9.
Lockley SW, Skeene DJ, James K, et al. Melatonin administration can entrain the free-running circadian system of blind subjects. J Endocrinol 2000; 164: R1–6.
Lusardi P, Piazza E, Fogari R. Cardiovascular effects of melatonin in hypertensive patients well controlled by nifedipine: a 24-hour study. Br J Clin Pharmacol 2000; 49: 423–7.
Monti JM, Cardinali DP. A critical assessment of the melatonin effect on sleep in humans. Biol Signals Recept 2000; 9: 328–39.
Naguib M, Samarkandi AH. The comparative dose-response effects of melatonin and midazolam for premedication of adult patients: a double-blinded, placebo-controlled study. Anesth Analg 2000; 91: 473–9.
Ohta Y, Kongo M, Sasaki E, et al. Preventive effect of melatonin on the progression of carbon tetrachloride-induced acute liver injury in rats. Adv Exp Med Biol 1999; 467: 327–32.
Pierce A. The American Pharmaceutical Association practical guide to natural medicines. New York: The Stonesong Press; 1999. p. 19.
Papavasiliou PS, Cotzias GC, Duby SE, et al. Melatonin and parkinsonism [letter]. JAMA 1972; 221: 88–9.
Rodriguez MA, Cabanillas F, Dang NH, et al. Lymphocyte changes in lymphoma patients receiving melatonin plus CHOP chemotherapy. Proc Ann Meet Am Soc Clin Oncol 2000;19:Abstract 72.
Rosenberg SI, Silverstein H, Rowan PT, Olds MJ. Effect of melatonin on tinnitus. Laryngoscope 1998; 108: 305–10.
Sack RL, Brandes RW, Kendall AR, Lewy AJ. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000; 343: 1070–7.
Sanders DC, Chaturvedi AK, Hordinsky JR. Melatonin: aeromedical, toxicopharmacologial, and analytic aspects. J Anal Toxicol 1999; 23: 159–67.
Shamir E, Laudon M, Barak Y, et al. Melatonin improves sleep quality of patients with chronic schizophrenia. J Clin Psychiatry 2000; 61: 373–7.
Shaughnessy AF. Melatonin: miracle or not? Fam Pract Recert 1996; 18: 46–8.
Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet 1998; 351: 1254.
von Bahr C, Ursing C, Yasui N, et al. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects—an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin. Eur J Clin Pharmacol 2000; 56: 123–7.
Waldhauser F, Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann NY Acad Sci 1985; 453: 205–14.
Williamson BL, Tomlinson AJ, Mishra PK, et al. Structural characterization of contaminants found in commercial preparations of melatonin: similarities to case-related compounds from 1-tryptophan associated with eosinophilia-myalgia syndrome. Chem Res Toxicol 1998; 11: 234–40.
Wright SW, Lawrence LM, Wrenn KD, et al. Randomized clinical trial of melatonin after nightshift work: efficacy and neuropsychologic effects. Ann Emerg Med 1998; 32: 334–40.
Wurzburger RJ, Kawashima K, Miller RL, Spector S. Determination of rat pineal gland melatonin content by a radioimmunoassay. Life Sci 1976; 18: 867–77.
Yie SM, Johansson E, Brown GM. Competitive solid-phase enzyme immunoassay for melatonin in human and rat serum and rat pineal gland. Clin Chem 1993; 39: 2322–5.
Zisapel N. The use of melatonin for the treatment of insomnia. Biol Signals Recept 1999; 8: 84–9.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sullivan, A., Cupp, M.J., Tracy, T.S. (2003). Melatonin (N-acetyl-5-Methoxytryptamine). In: Cupp, M.J., Tracy, T.S. (eds) Dietary Supplements. Forensic Science and Medicine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-303-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-59259-303-3_17
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9726-7
Online ISBN: 978-1-59259-303-3
eBook Packages: Springer Book Archive